The future trajectory of the immunology market will be defined by the balance between established gold-standard treatments and emerging therapeutic classes. The enbrel Market occupies a resilient position due to its well-characterized safety profile and deep clinical familiarity among healthcare practitioners worldwide. While newer targeted therapies, such as JAK inhibitors and IL-17 blockers,...